Literature DB >> 7890236

DNA flow cytometric evaluation of cell cycle distribution in ulcerative colitis: a proposed method for assessing severity of disease.

F Bortoluzzi1, M Valentini, C Cernigoi, G Toffoli, M Boiocchi, M Poletti, M Sozzi, M Fornasarig, R Cannizzaro, E Bertolissi.   

Abstract

The assessment of disease severity in ulcerative colitis depends mainly on subjective variables, and an objective method of assessing mucosal inflammation is needed. Determination of the synthetic phase of the cell cycle is an accurate expression of inflammatory activity in the colonic mucosa. The aim of the study was to find out if the proliferative index or the synthetic phase (S phase) of the colonic mucosa of patients with ulcerative colitis, as evaluated by DNA flow cytometry, is a reliable and reproducible marker of disease activity. Sixty consecutive patients with ulcerative colitis of different degrees of activity were entered into the study and submitted to colonoscopy plus multiple rectal biopsies. Disease severity was defined for each patient by means of a clinical, endoscopic, and histological score. Flow cytometry was used to calculate the proliferative index and the S phase of the cell cycle. A statistically significant correlation (p < 0.001) was found between all indices of severity. It is suggested that flow cytometric evaluation of the cell cycle in the rectal mucosa may be an efficient method of assessing severity of disease and efficacy of medical treatment in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890236      PMCID: PMC1382352          DOI: 10.1136/gut.36.1.50

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  The role of sigmoidoscopy and rectal biopsy in diagnosis and management of inflammatory bowel disease: personal experience.

Authors:  S E Fochios; B I Korelitz
Journal:  Am J Gastroenterol       Date:  1988-02       Impact factor: 10.864

3.  Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.

Authors:  P Gomes; C du Boulay; C L Smith; G Holdstock
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

4.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

5.  Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score.

Authors:  A Pera; P Bellando; D Caldera; V Ponti; M Astegiano; C Barletti; E David; A Arrigoni; G Rocca; G Verme
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

6.  Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study.

Authors:  C Hammarberg; P Slezak; B Tribukait
Journal:  Cancer       Date:  1984-01-15       Impact factor: 6.860

7.  A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

Authors:  J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

8.  5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.

Authors:  L R Sutherland; F Martin; S Greer; M Robinson; N Greenberger; F Saibil; T Martin; J Sparr; E Prokipchuk; L Borgen
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

9.  Flow cytometry of biopsy specimens from ulcerative colitis, colorectal adenomas, and carcinomas.

Authors:  B Børkje; J Høstmark; D W Skagen; E Schrumpf; O D Laerum
Journal:  Scand J Gastroenterol       Date:  1987-12       Impact factor: 2.423

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more
  1 in total

1.  Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice.

Authors:  A Mizoguchi; E Mizoguchi; C Chiba; A K Bhan
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.